Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

Roche

Status: Completed

Conditions: Rheumatoid Arthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02008266

ML25384

Details and patient eligibility

About

This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.

Enrollment: 532 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Rheumatoid arthritis progressing for < 2 years.

Exclusion criteria

• Rheumatoid arthritis progressing for < 3 months.
• Rheumatoid arthritis onset at < 18 years of age.
• Participation in another clinical study.
• Rheumatoid arthritis related connective tissue disorder.
• Any neuropsychological disorders.

Trial design

532 participants in 1 patient group

Patients with Rheumatoid Arthritis